Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01034865 · ClinicalTrials.gov registry record
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 750
- Enrollment target
NCT01034865: Completed study, sponsored by Stanford University.
NCT01034865 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 750 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01034865 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
Study Summary
To identify risk factors for the development and diagnosis of hepatocellular CA in patients with chronic hepatitis C and to use the data to ultimately develop an effective screening program.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2001-05 |
| Est. Completion | 2009-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01034865
The ClinicalTrials.gov registry entry for NCT01034865 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01034865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01034865 about?
NCT01034865 is a clinical study titled "Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer". To identify risk factors for the development and diagnosis of hepatocellular CA in patients with chronic hepatitis C and to use the data to ultimately develop an effective screening program.
What is the current status of trial NCT01034865?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2001-05. Estimated completion is 2009-06.
Who is sponsoring clinical trial NCT01034865?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.